#	Pagina
attuale pagina	/open-h2020/projects/218935/index.html
-1	/open-h2020/projects/214925/index.html
-2	/open-h2020/per-topic/decade/list/index.html
-3	/open-h2020/projects/219960/index.html
-4	/open-h2020/projects/218577/index.html
-5	/open-h2020/projects/195705/index.html
-6	/open-h2020/per-topic/pressed/list/index.html
-7	/open-h2020/per-topic/behaving/list/index.html
-8	/open-h2020/per-topic/remeshing/list/index.html
-9	/open-h2020/projects/222807/index.html
-10	/open-h2020/per-topic/genuineness/list/index.html

Opendata, web and dolomites

ACOUPLASMA SIGNED

Market maturation of a blood plasma separation module enabling plasma based diagnostic point-of-care devices

Total Cost €

EC-Contrib. €

Partnership

Views

Outcomes and
results

ACOUPLASMA project word cloud

Explore the words cloud of the ACOUPLASMA project. It provides you a very rough idea of what is the project "ACOUPLASMA" about.

cells analytical life decision efficiency forces proving vitro acoustic position market benchtop centrifugation particles consumables company first maturation plasma sold feasibility facilitates players samples line point technological acoutrap blood modules hence cell cartridges separation tests acouwash reputation offers industry workflow laborious care patient efficacy enrich handle accelerate biology pipeline consuming science successful small wash clinical named disruptive concentrations chip acouplasma integration components global innovation module companies solution time finances safety perform laboratories eliminating acousort almost flow selling operation diagnostic healthcare hospitals normally laboratory strategy introduction separate technique automation automated lab quality platform

Project "ACOUPLASMA" data sheet

The following table provides information about the project.

Coordinator	ACOUSORT AB Organization address address: MEDICON VILLAGE city: LUND postcode: 223 81 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Sweden [SE]
Project website	http://www.acousort.com/about-us/
Total cost	71˙429 €
EC max contribution	50˙000 € (70%)
Programme	1. H2020-EU.3. (PRIORITY 'Societal challenges) 2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs) 3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
Code Call	H2020-SMEInst-2018-2020-1
Funding Scheme	SME-1
Starting year	2018
Duration (year-month-day)	from 2018-10-01 to 2019-02-28

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	ACOUSORT AB ACOUSORT AB Organization address address: MEDICON VILLAGE city: LUND postcode: 223 81 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	SE (LUND)	coordinator	50˙000.00

Map

Project objective

AcouSort has developed a technological platform based on acoustic forces to separate, enrich and wash cells and other particles. This technique can perform almost any operation that is normally done by centrifugation in the biology or clinical lab. With an automated flow we can handle small samples and low cell concentrations. We are currently selling two R&D benchtop devices based on this technology, named AcouTrap and AcouWash. In our pipeline is AcouPlasma the first example of the company’s long-term strategy to provide components and modules for life science analytical/diagnostic devices. The AcouPlasma solution offers high quality separation of blood plasma from cells in whole blood in a chip, eliminating the need of time consuming and laborious centrifugation. Through a unique design it facilitates cost-effective automation and in line integration with the sample workflow required to take plasma-based laboratory tests to point-of-care. Hence, it has the potential to increase the patient safety, healthcare decision making efficacy and hospitals/laboratories efficiency, finances and reputation. The AcouPlasma module will be integrated into cartridges for Lab-on-Chip test devices to be sold by major life science companies in the in vitro diagnostic market. We have conducted technical feasibility studies with main players in the industry proving the functionality of the separation module for plasma analysis. With the current project we aim to accelerate the maturation of our disruptive solution for introduction into the global blood processing devices and consumables market. With the successful implementation of the Innovation Project we will be in a strong position to exploit a very significant market.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ACOUPLASMA" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ACOUPLASMA" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Colourganisms (2020)

Microbial production of custom-made, pure and sustainable anthocyanins

Woodywood pickering (2019)

Bio-based (fully renewable) cost effective Polymer for new generation of ecological Coatings leveraging a disruptive innovation in the use of Pickering emulsion.